dual glp-1/glucagon receptor agonists Current Insights, Advantages and Challenges of Small Molecule Glucagon-like Peptide 1 Agonists: A Scoping Review Schematic illustration of monoagonists, dual

Part 1 of a 3 part series

has details on the plan to remove auto-injectors in order to allow greater access to patients at lower prices.

Allulose, a rare sugar, has been shown to stimulate GLP-1, reduce blood sugar spikes, and help control appetite without the side effects of medications

However, the causal relationship between GLP-1RAs and psychiatric and neurodevelopmental conditions remains unclear

Methods Adults (18 years old) with T2D required at least one prescription for injectable semaglutide at index date (treatment switch), at least one prescription for any other GLP-1 RA in the previous 365 days, a baseline HbA1c and/or weight measurement in the 90 days pre-index and a follow-up measurement at 180 and 365 days post-index